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ABSTRACT
THE EFFECT OF DIFFERENT INTERFACES ON AEROSOL DELIVERY IN SIMULATED
SPONTANEOUSLY BREATHING ADULT WITH TRACHEOSTOMY
By
Alaa Bugis, BSRC
Background: The delivery of an aerosol via a tracheostomy tube has been previously described
with both a tracheostomy collar and a T-piece, but not with a Wright mask, or aerosol mask. The primary
purpose of this study was to quantify lung doses using different interfaces: tracheostomy collar, Wright
mask, and aerosol mask. The secondary purposes were to compare albuterol delivery between an opened
vs. a closed fenestration hole and also to determine the effect of inspiratory time:expiratory time (I:E)
ratio on aerosol delivery.
Methods: A teaching mannequin (Medical Plastic Labs, Gatesville, TX) with a tracheostomy
opening was used. Two of the mannequin's bronchi were connected to a "Y" adaptor, which was attached
to a collecting filter (Respirgard ™ II 303, Vital Signs, Englewood, CO), which was connected to a
breathing simulator (Harvard Apparatus Dual Phase Control Respirator Pump, Holliston, MA) through a
corrugated tube. Settings for spontaneous breathing were respiratory rate 20/min, and tidal volume 400
mL. The I:E ratios were adjusted in the first and second comparisons at 2:1 and 1:2, respectively. The
nebulizer was operated by a flow meter (Timemeter, St. Louis, MO) at 8 L/min with 100% oxygen. In
every condition, the flow was discontinued at the end of nebulization. The nebulizer was attached to the
tracheostomy collar (AirLife™, Cardinal Health, McGaw Park, IL) in the first group, the Wright mask
(Wright Solutions LLC, Marathon, FL) in the second group, and the aerosol mask (AirLife™, Cardinal
Health, McGaw, IL) in the third group. Drug was eluted from the filter and analyzed by
spectrophotometry (276 nm).
Data Analysis: Paired t-test, one-way analysis of variance (ANOVA), repeated measures
ANOVA, post-hoc and pairwise comparisons were performed at the significance level of .05, using
PASW version 18.0.
Results: Aerosol delivery was greater with the tracheostomy collar than the Wright mask and
aerosol mask (p < .05). Closing the fenestration hole increased aerosol deposition significantly at 2:1 ratio
(p = .04) compared to opening the fenestration at 1:2 ratio. I:E ratio and aerosol delivery were directly
related. Increasing I:E ratio from 1:2 to 2:1 improved aerosol delivery significantly with tracheostomy
collar-fenestration opened (p = .009), Wright mask (p = .02) and aerosol mask (p = .01).
Conclusion: This study indicates that the use of a tracheostomy collar is the best method of
delivering aerosol therapy among the three interfaces. The I:E ratio of 2:1 caused greater aerosol
deposition than 1:2 ratio. The aerosol deposition was better when the fenestration hole was closed
compared with opened fenestration.
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CHAPTER I
INTRODUCTION
In the United States, 16,000,000 people have chronic obstructive pulmonary disease
(COPD). Every year, there are 120,000 deaths from COPD, making it the fourth highest cause of
death (Johnson, 2007). Patients with acute or chronic respiratory failure are usually patients who
have COPD or asthma. Those patients may require prolonged respiratory care and mechanical
ventilation through endotracheal tubes (ETTs) or tracheostomy tubes. Tracheostomy is usually
suggested if intubation is planned to last longer than several weeks. In a patient requiring more
than 14 days of ventilatory support, a tracheostomy procedure is recommended within the first 2
days of intubation. It has been stated that if a tracheostomy performed in the first 2 days rather
than after Day 14, it will markedly reduce the number of ventilator and intensive care unit days,
and decrease both the incidence of pneumonia and overall mortality (Pierson, 2005).
There are many potential benefits of tracheostomy use such as the ability to
communicate, the possibility for oral feeding, safe nursing care, and improving a patient's
comfort. In addition, using tracheostomy tubes will result in lesser need for sedation and lower
resistance, compared to endotracheal intubation. In turn, this will lead to a shorter hospital stay in
the intensive care unit and will facilitate a more successful recovery. It has been speculated that
the use of tracheostomies might decrease ventilator-associated pneumonia by preventing micro
aspiration of secretions, help in the weaning process by reducing dead space and airway
resistance, and improve secretion clearance (Durbin, Perkins, & Moores, 2010). The improved
secretion clearance with the use of tracheostomy tubes helps in making patients more
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comfortable, requiring less sedation, and reducing the likelihood of aspiration through enhanced
glottic function.
The treatment of asthma patients includes the use of inhaled long-acting β-agonists and
corticosteroids. The treatment of COPD patients includes the use of inhaled long-acting
anticholinergic and long-acting β-agonists, which are available in dry powder aerosol form and
created for oral deep inhalation. However, the delivery devices for long-acting β-agonists and
long-acting anticholinergics are not designed for patients with artificial airways. A gas-powered
jet nebulizer is commonly used to deliver aerosol medications. The aerosol reaches patients’
airways through a mouthpiece or an aerosol mask. In a review by Hess (2000) it was stated that
there was no significant difference in clinical response has been found between the mouthpiece
and the aerosol mask. Moreover, delivering albuterol medication via tracheostomy tube is
affected by humidification, bias gas flow, and interface. One study conducted by Piccuito and
Hess (2005) concluded that the use of a T-piece resulted in more albuterol delivery as compared
to a tracheostomy collar (p = .001). Moreover, the most effective delivery involved the nebulizer
attached to the tracheostomy tube without additional gas flow (p < .001).
A Wright mask has been recently developed for humidification purposes for patients with
tracheostomies. It consists of both a tracheostomy collar and an aerosol mask. No published
articles on the Wright mask have been found in a literature search. However, in the web site on
the Wright mask (www.wrighttrachsolutions.com/Abstracts) there is an abstract by Carvalho et
al. (2010) that evaluated the efficacy and feasibility of the Wright mask. The abstract concluded
that there are no large differences noted in blood oxygen saturation, comfort, ease of use, or ease
of breathing in patients with tracheostomies used the Wright mask compared to both the
tracheostomy collar and the aerosol mask.
2

The Importance of the Study
This study is important because the tracheostomy tube has not been very well studied. No
studies have been found regarding aerosol delivery with tracheostomy collar, Wright mask, and
aerosol mask all together. It is important to examine the Wright mask because it may be used
with patients even though its use has not yet been studied. Also, the effect of I:E ratio and
fenestration hole on aerosol delivery need to be investigated in order to provide guidance to
clinicians on how to administer aerosol therapy.
Study Purposes
The delivery of aerosol therapy via a tracheostomy tube has been described with both a
tracheostomy collar and a T-piece (Piccuito & Hess, 2005), but not a Wright mask or an aerosol
mask. The primary purpose of this study was to quantify lung dose using different interfaces:
tracheostomy collar, Wright mask, and aerosol mask. The secondary purpose was to compare
albuterol delivery between an opened vs. a closed fenestration hole and also to determine the
effect of inspiratory time to expiratory time (I:E) ratio on aerosol delivery.
Research Questions
Upon review of the literature, three important research questions arose:
1. What is the amount of albuterol delivered to the lungs with different interfaces
using an open fenestration hole of the tracheostomy tube?
2. How much albuterol is delivered using a tracheostomy collar, while the
fenestration hole is opened and closed?
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3. What is the effect of I:E ratio on aerosol delivery in simulated spontaneously
breathing adults with tracheostomy?
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CHAPTER II
REVIEW OF LITERATURE
A literature review was performed using terms related to aerosol therapy through
tracheostomy tubes. The I:E ratio was also searched. The databases used were Medline, PubMed,
Science Direct, and Web of Science through both the Georgia State University and the
Northeastern University libraries. From an exhaustive search, the research questions were
formulated to investigate how aerosol administration changes through interfaces when I:E ratio
and fenestration hole are manipulated.
Tracheostomy
Epstein (2005) indicated that the trachea was used as an easy entryway to the airways at
the bedside. It provided an inlet for urgent airway cannulation in the case of acute upper airway
obstruction. In addition, it provided an inlet for chronic airway access after laryngeal surgery.
Tracheostomy tubes, in general, were used to allow the discontinuation of ETTs. Most of the
studies indicated that the tracheostomy tube reduced both airflow resistance and work of
breathing when compared to ETTs. Tracheostomy tubes differ from ETTs because they have a
portable inner cannula that can be easily removed for cleaning. In addition, the tracheostomy
tube has a fenestration hole that can be closed to provide proper mechanical ventilatory support.
Tracheostomy tubes have important benefits in improving weaning success.
Pierson (2005) reported in a review paper that using tracheostomy tubes might facilitate
weaning from ventilatory support. There were many reasons mentioned why tracheostomy tubes
can improve the weaning process: (1) A tracheostomy tube can decrease airway resistance; (2) it
reduces the extrathoracic dead space; (3) it enhances clearance of secretions from patients’
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airways; (4) it decreases need for sedation; (5) it lowers the risk of aspiration; and (6) it also
decreases the work of breathing compared to a translaryngeal ETT with the same internal
diameter. The difference in dead space between a tracheostomy tube and an ETT is very low.
However, the literature reviewed from laboratory experiments, short-term physiologic studies on
clinically stable patients, and evidence from clinical trials indicates that airway resistance and
anatomic dead space are reduced with tracheostomy tubes. The researcher reported that one
clinical trial showed that there was no benefit to early tracheotomy. He also reported that in a
recent clinical trial, investigators found that percutaneous dilational tracheotomy performed in
the first 2 days of ventilatory support dramatically (1) reduced ventilator and intensive care unit
days; (2) lowered the incidence of pneumonia; and (3) decreased mortality rate, when compared
with tracheostomy performed after the Day 14. Tracheotomy tubes helped liberating patients
from ventilatory support. However, clinician bias as well as physiologic effects may affect this
conclusion.
Adoga and Ma'an (2010) investigated the indications and outcomes of pediatric
tracheostomy in pediatric patients in a Nigerian teaching hospital. In addition, they wanted to
know if there was a change in the trend of the environment compared to other centers.
Historically, the most common indication for use of tracheostomy in children was acute
inflammatory airway obstruction. Nowadays, the most common indication to use tracheostomy
in children is prolonged intubation. The study was a retrospective chart review of 46 patients.
There were 29 males and 17 females with ages ranging from 2 months to 15 years. All the 46
patients had their tracheostomy procedures done between January 2000 and December 2008 and
were presented to their otorhinolaryngological facility. Most of the patients who had a
tracheostomy (69.6%) were of ages ranging from 6 to 10 years old. Forty tracheostomies (87%)
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were performed as emergencies while six (13%) were performed as elective procedures. The
most common indication for tracheostomy was upper airway obstruction (n = 29, 63%) such as
respiratory papilloma (n = 20). All the cases employed transverse skin incision. There were no
intra-operative complications recorded. However, the postoperative complication rate was
15.2%. The duration of tracheostomy ranged from 5 days to 3 months. All patients were
successfully decannulated. There were eight mortalities (17%). However, there was no
tracheostomy-related mortality. Researchers concluded that there is no increase in the incidence
of tracheostomy in patients less than 1 year of age. The percentage of tracheostomy procedures
performed on patients aged less than 5 years old was 21.7%. The group that had the fewest
tracheostomy procedures was within the age range of 11 to 15 years and the percentage was
8.7%. Their conclusion was that pediatric tracheostomy is safe when performed in a tertiary
hospital setting.
Spontaneous Breathing and Tracheostomy
O'Callaghan et al. (1989) presented a case report of 2 ½-year-old girl with a tracheostomy
who was diagnosed with asthma disease. Investigators tested a modified volumatic spacer device
to deliver beclomethasone diproprionate, ipratropium bromide, and salbutamol aerosols to the
child. A volumatic spacer device was prescribed into which both bronchodilator and prophylactic
agents could be activated. The inhalation port of the volumatic spacer was modified by a series
of tubes, connected with the tracheostomy tube, giving an airtight seal. On inhalation, the valve
in the spacer device opened, allowing the aerosol to be inhaled. On expiration, the valve closed
and air was dispelled though small holes near the inhalation port. The spacer device resulted in a
dramatic improvement in symptoms, and marked reduction in the time spent inhaling the drugs.
The advantages of this modified spacer device were several; (1) The modified spacer is easy to
7

use; (2) time required for taking therapy decreased from several hours to 15–20 minutes per dose
daily; (3) the tracheostomy tube needed to be changed less frequently, from every day to weekly;
and (4) the modified spacer had the ability to administer adequate doses of inhaled steroids and
bronchodilators to improve asthma control.
Meeker and Stelmach (1992) reported that the spacer device helped ensure consistent
delivery of medications to the bronchial tree. They also indicated that it minimizes the
oropharyngeal deposition of pressurized metered dose inhaler (pMDI) medication. Inhaled
corticosteroid is available only in pMDI form. Inhaling corticosteroids by a spacer can minimize
its side effects. However, patients with artificial airways such AirIon and Jackson tracheostomy
tubes, and patients with hand limitations such as patients with severe arthritis, hand weakness,
and those with very small hands may be unable to successfully activate the inhaler. Meeker and
Stelmach described several modifications to help this population receive their aerosol therapy
effectively. They adapted spacer devices that required few simple modifications of the standard
pMDI spacer to use them in a patient with a tracheostomy. They used standard Shiley, Portex, or
Communitrach 15-mm adaptors, and Kamen-Wilkens on tracheostomy tube. The Aero Chamber
with a mask or InspirEase Bag consisted of soft pliable silicone that easily conformed to the
patient's neck. The technique of using this spacer was to apply gentle pressure by placing one
hand on the mask at the stoma site while the other hand activates the pMDI. It was also adapted
to fit an indwelling tracheostomy tube. The researchers mentioned that patients with hand
limitations may benefit from the use of an arthritic aid (VentEase, Glaxo) which can be inserted
into an Aero Chamber thereby allowing the use of a spacer device in this population. This Aero
Chamber with mask simplified the delivery of pMDI medications in patients with an open stoma.
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Subhedar et al. (1999) reported a study of four cases of infants with chronic lung disease
(CLD). Those patients had tracheostomy procedures because of subglottic stenosis. The
tracheostomy was performed due to the degree of upper airway compromise, which resulted in a
failure of extubation. The other reason for performing a tracheostomy was due to further
narrowing that occurred with a concurrent infection of the upper respiratory tract. The purpose of
their report was to highlight the feasibility of delivering supplemental oxygen and the
administration of inhaled medications in such patients. Three of the patients received
supplemental oxygen. The oxygen therapy was administered via a nasal cannula attached to open
tracheostomy tube and stabilized by taping the tubing to each side of the back of patient’s neck.
Two of the patients received nebulized bronchodilators. The nebulizer was held over the
tracheostomy tube opening, and patients were breathing normally. All four patients received
bronchodilator therapy, and two received inhaled steroids. Aerosol inhalers administered via
aerosol spacer device were directly attached to the tracheostomy tube. This report did not
mention information about the deposition of aerosol medications. However, it indicates the
importance of giving advice to patients on how to administer aerosol therapy. As we studied the
effect of I:E ratio on aerosol therapy, we will give advice to patients on how to inhale aerosol
therapy for better outcomes. The researchers concluded that therapists and parents who provided
inhaled therapy and supplemental oxygen to children with CLD who have tracheostomy should
be advised and trained of administering such therapy before discharge from a hospital.
Piccuito and Hess (2005) investigated whether albuterol delivery through a tracheostomy
tube is affected by the type of patient interface (T-piece vs. mask), aerosol delivery method
(pMDI vs. nebulizer), humidification of the inspired gas, and bias flow. A dual-chambered lung
model was used to stimulate a patient's spontaneous breathing with a lift bar placed between the
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chambers. The settings they used were a respiratory rate of 20 breaths/min, tidal volume of 400
mL, and I:E ratio of 1:2. A cuffed tracheostomy tube with an inner diameter of 8 mm was placed
through a semicircular model that simulated a patient's neck. In the aerosol nebulizer
experiments, four combinations of humidification and gas flow were used as follows: (1) Heated
humidity generated using a Concha-Therm. The oxygen outlet flow was around 30 L/min. The
heat of the humidifier was set to provide a gas temperature at the proximal airway of
approximately 30 °C with relative humidity greater than 95%; (2) heated aerosol generated using
a heater and nebulizer. A flow meter was adjusted to power oxygen gas flow of approximately
30 L/min. The gas temperature measured at the proximal tracheostomy tube was about 30 °C and
the relative humidity was greater than 95%; (3) high flow without additional humidification
(around 30 L/min); and (4) a tracheostomy tube without additional flow that was attached to a
nebulizer. The aerosol nebulizer device was filled with 4 mL of 2.5 mg albuterol medication, and
operated at a flow rate of 8 L/min. The nebulizer was tested with a tracheostomy collar and a Tpiece. An aerosol spacer device was used for the pMDI experiments and actuation of the inhaler
(100 µg/ actuation) was synchronized with inhalation. Four actuations were delivered separated
by more than 15 seconds. A T-piece valve was used with a one-way valve attached either distally
or close to the aerosol spacer device without the use of additional flow. A filter was placed
between the distal end of the tracheostomy tube and the lung model. The filter was washed to
measure the amount of albuterol detected by ultraviolet spectrophotometer. The most efficient
aerosol delivery method was with the use of the pMDI with a T-piece valve and attachment of a
one-way valve placed in the proximal position (p < .001). In the nebulizer experiments, the most
efficient delivery method was with no flow other than to power the nebulizer with a T-piece (p <
.001). This study had five major findings: (1) there was a delivered amount of albuterol aerosol
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through a tracheostomy tube with the use of a nebulizer and also with the use of a pMDI; (2) it
was inefficient to deliver albuterol using high gas flow with the nebulizer; (3) the T-piece was
more efficient in delivering albuterol than the tracheostomy mask; (4) the pMDI with valved
holding chamber was more efficient than the nebulizer; and (5) the pMDI was more efficient
when a T-piece was placed close to the spacer device than when placed in the distal position.
They concluded that albuterol delivery through the tracheostomy tube was affected by the
patient's interface, delivery method, and bias gas flow.
Lin et al. (2007) measured the albuterol delivery of a jet nebulizer in three different
pediatric face masks and at three different distances from the face. There were three face masks
included a standard pediatric face mask, a proprietary pediatric face mask shaped to resemble a
dragon face, and a proprietary pediatric face mask shaped to resemble a fish face. Researchers
used an infant mannequin face connected to a lung simulator to stimulate a spontaneously
breathing patient. The inhaled aerosol mass was measured with the face masks at distances of 0
cm where the face mask placed directly to the model at 1 cm and 2 cm. For every experiment,
the nebulizer cup was filled with 3 mL of albuterol sulfate and generated by a flow of 8 L/min of
oxygen gas. A 5-minute nebulization time was set for each test. They measured inhaled mass by
collecting the aerosol on a 2-way anesthesia filter that was attached to the back of the
mannequin’s oral opening via a 15-mm silicon adapter. They also measured the remaining
amount of drug left in the nebulizer cup and estimated the wasted drug lost to the atmosphere.
The mean inhaled values of the nominal dose percentage at 0 cm, 1 cm, and 2 cm were as
follows: In the standard face mask, 2.18 %, 1.45 %, and .92 %, respectively. In the dragon face
mask, 2.65 %, 1.7 %, and 1.3 %, respectively. In the fish face mask, 3.67 %, 2.92 %, and 2.26 %,
respectively. Statistically, among the three face mask experiments there was a significant
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difference in delivering aerosol between the 0 cm and 2 cm distance (p < .001). The highest
inhaled mass of albuterol significance was for the fish face mask (p < .001) among all three
distances. When the mask was further separated from the face, the inhaled mass was significantly
reduced. The study concluded that the face mask design affected the inhaled mass delivered in
pediatric patients.
Johnson (2007) studied aerosolized drugs delivered through a tracheostomy tube. He
recruited 23 patients in his study. The study assessed the clinical ease vs. the clinical difficulty of
aerosol delivery. He designed interface to connect an Aerolizer and a HandiHaler to a
trachestomy tube. The study indicated that aerosol therapies were readily delivered to all
patients. Nineteen of the 23 patients (83%) were able to take the treatment on their own. A bagassist was successfully used in the four patients who were unable to take the treatment
effectively on their own. Johnson also indicated that the aerosol delivery time was less than 3
minutes. It was concluded that aerosol therapy can be easily delivered through a tracheostomy
tube if the proper interface is used.
Keck et al. (2008) compared inhalation with molecular water (vaporizing humidifier) and
particulate water (trachea spray) in patients with tracheostomies who were breathing
spontaneously. In their study, they used a randomized two-way crossover study design and a
prospective, comparative, nonblinded study. They measured the temperature and tracheal
humidity before and after the use of the tracheal spray and the vaporizing humidifier for 1 week.
They found that after both spray and inhalation, tracheal temperature and total water content
increased significantly. The temperature gradient between tracheal air and ambient was
significantly higher after spray compared to after inhalation. The water gradient after spray and
inhalation increased nonsignificantly. The water gradient after spray or inhalation did not differ
12

significantly. The study concluded that molecular water was not superior to particulate water
because humidity and temperature increased after both forms of water delivery. A tracheal spray
may offer additional benefits in postoperative tracheostomy care for its ease of use, portability,
and moisturizing effect.
Mechanical Ventilation and Tracheostomy
Fuller et al. (1994) performed a study to compare aerosol administrations in ventilated
patients. The researchers used four different devices: (1) a 167 mL cylindrical chamber 10.5 ×
4.5 cm; (2) a 700 mL cylindrical chamber 11 × 9 cm; (3) a non-chamber device that allowed
pMDI attachment to the inspiratory line of the ventilator circuit; and (4) a non-chamber device
that allowed pMDI attachment directly into the ETT or tracheostomy tube. For their study, they
recruited 48 patients who were mechanically ventilated. Subjects were given four puffs of
fenoterol labeled with technetium 99m pertechnetate via a metered-dose inhaler. At the bedside,
a portable gamma camera was used to identify images of the thorax. The study showed that the
deposition of radioactivity in the lungs was 5.53 ± .72, 6.33 ± 1.16, 1.67 ± .43, and 3.89 ± .52
percent for devices (1), (2), (3), and (4), respectively. The researchers did not specify whether
these data were obtained with ETTs or tracheostomy tubes. There was a statistically significant
difference in delivery only between devices (1) and (3) and between devices (2) and (3) (p =
.004). In addition, they found a statistically significant difference between inhalation from both
chamber devices and the inline non-chamber device, but not between inhalation of other devices.
The study concluded that a non-chamber device significantly provided smaller amounts of
aerosol from the pMDI to the lung than a chamber device in the inspiratory ventilator line
similarly positioned.
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O'Riordan et al. (1994) characterized factors that may affect aerosol delivery such as
nebulizer device, drug volume, humidity, and ventilator settings. The researchers also
characterized technical factors that may affect deposition loads such as radio-labeled compounds.
They designed a study to evaluate nebulized aerosol delivery to ventilated patients in optimal
situations. Seven patients were recrutied for this study. All patients were mechanically
ventilated through a tracheostomy tube. The humidifier was not operated. For aerosol
experiments, researchers used a saline solution labeled with 99mTechnetium bound to human
serum albumin 99mTc-HSA. They administered it via a jet nebulizer that was joined into the
ventilator circuit. The flow was discontinued at the end of nebulization. A mass balance/filter
method was used to calculate the inhaled and deposited radioactivity. A gamma camera scanner
was used to verify the distribution areas of the deposited radioactivity before and after the
tracheostomy tube removal. The measured radioactivity at each site was expressed in a
percentage of nebulizer charge. The results showed that the ventilated patients inhaled an
average of 30.6 %. In addition, the mean deposition in the tracheostomy tube during inspiration
was 2.6 %.
Palmer et al. (1998) conducted a study to determine whether aerosolized antibiotics can
be delivered effectively to the lower respiratory tract in mechanically ventilated patients and to
identify possible clinical reactions to these agents. Six patients were recruited with tracheostomy
tubes. The patients received nine doses of nebulized therapy of gentamicin (80 mg) or amikacin
(400 mg) every eight hours for 14 to 21 days. The researchers measured the doses to the lung
using antibiotic concentrations and radio-labeled aerosols in airway secretions. The response was
assessed by (1) changes in the volume of airway secretions, (2) effect on bacterial cultures, and
(3) changes in the inflammatory cells and mediators of inflammation of the airway secretions.
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The study concluded that inhaling nebulized aminoglycoside was efficient. Therefore,
aerosolized antibiotics can make a significant impact on airway secretions.
Shorten et al. (2000) conducted a study to determine the effectiveness and safety of
salbutamol delivered via a metered dose inhaler to intubated rabbits. The research was performed
on five groups of rabbits. The first three groups had tracheal intubation through a tracheostomy
and received five puffs of 99mTcO4 salbutamol. Group (1) inhaled the drug at elbow connector.
Group (2) inhaled the drug through a catheter with its distal tip placed at the midpoint. Group (3)
inhaled the drug at the bevel of the ETT. Rabbits in Group (4) were not exposed to any
interactions. Group (5) had tracheal intubation through the mouth and received five puffs of
salbutamol inhaled at the bevel of the ETT. Delivery efficiency was expressed as the ratio of
radioactivity from the trachea and lungs to the total radioactivity of the delivered dose.
Histopathologic injury scores were assigned to each lung specimen or trachea. Results showed
that the delivery efficiency was 30 times greater with the full catheter in Groups (3) and (5) than
the elbow in Group (1). The study concluded that the increased efficiency acquired by the
administration of metered dose salbutamol at the distal tip of the ETT was not necessarily related
with increased epithelial injury.
Smaldone (2004) reported that antibiotic drugs in the form of aerosols were very useful in
intensive care. A human model was created of trachea-bronchitis in intubated patients. The
model provided daily specimens of respiratory secretions, allowing serial investigations of
airway inflammation and testing of different therapy modes. The local infection was determined
by a unique method of measured sputum specimen. Laboratory models were invented to explain
the factors that restrict aerosol delivery to intubated patients. Those models facilitated clinical
experiments that determined the possible indications for targeted aerosol treatment to patients at
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risk for lower respiratory disease. It was found that when inhaling antibiotic drugs via nebulizers,
the drug levels in pulmonary secretions exceed by several doses when compared to the levels
expected with intravenous administrations.
Dhand (2004) reported that among aerosol devices such as nebulizers, dry powder
inhalers, and metered-dose inhalers, only nebulizers and metered-dose inhalers are typically used
for aerosol delivery to patients on mechanical ventilators. Previously, the artificial airway and
ventilator circuit were thought to be serious obstacles to deliver aerosols effectively to patients
on mechanical ventilators. In the past decade, in vivo and in vitro investigations assisted good
understanding of the complex array of factors that affected inhaled drug delivery in mechanically
ventilated patients. Many investigators have shown that, with careful attention to aerosol delivery
technique, the effectiveness in patients on mechanical ventilators is proportional to that in
ambulatory patients.
Inspiratory to Expiratory (I:E) Ratio
Few references discussed the I:E ratio. For that reason the following articles are reviewed
although they are not strongly related to this study.
Boros (1979) studied the relationship of I:E ratio to optimum oxygenation and
ventilation. Twelve neonates who had severe lung disease were recruited. Subjects were
mechanically ventilated with volume-preset infant ventilators using different I:E ratios and
different airway pressure waves. The ventilator settings of fraction of inspired oxygen (FIO2),
tidal volume (Vt), respiratory rate , and positive end expiratory pressure (PEEP) remained
constant. The I:E ratios were increased by reducing inspiratory flow rate or holding the
inspiratory time. For each I:E ratio and pressure wave combination, the researcher measured and
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compared the mean airway pressure (MAP), peak inspiratory pressure (PIP), hydrogen ion
concentration (pH), partial pressure of oxygen in arterial blood (PaO2), partial pressure of carbon
dioxide in arterial blood (PaCO2), and blood pressure. The study indicated that there was a direct
relationship between oxygenation and mean airway pressure. The mean airway pressure can
change with any change in I:E ratio, PEEP, or airway pressure wave. The study concluded that
an I:E ratio and pressure wave combination helped optimize oxygenation, ventilation, and mean
airway pressure.
Stewart et al. (1981) assessed the effects of changing ventilator parameters on blood
gases, intracranial pressure (ICP), and MAP. Researchers recruited 20 neonates with respiratory
failure which required mechanical ventilation. The study involved random changes in I:E ratio,
PEEP, and PIP. The MAP, PaO2, ICP, and end-tidal PCO2 were observed continuously. The
study showed a significant relationship between MAP and PaO2. The mean change in PaO2/MAP
was 4.92 torr. The change of PaO2/MAP was highest for changes in PEEP (p < .001), followed
by PIP (p < .001), and I:E ratio (p < .05), respectively. The association between changes in PIP
and PEEP vs. PaCO2 and PH was significant. Decreases in PIP and increases in PEEP resulted in
an increase in PaCO2 and a reduction in pH. In addition, increases in PIP and decreases in PEEP
resulted in a reduction in PaCO2 and an increase in pH. There was no significant association
between ICP and MAP. However, there was a significant relationship between changed ICP and
PaCO2 during changes in PIP (p < .001). This study concluded that increases in PEEP led to
elevations in PaO2 per change in MAP, followed by elevations in PIP and I:E ratio.
Lim et al. (1999) investigated whether extending the I:E ratio of the mechanical ventilator
would decrease the heterogeneity of regional ventilation and enhance gas exchange to a greater
degree than in gas ventilation (GV). Researchers inducted 18 rabbits with acute lung injury by
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saline solution lavage. Three I:E ratios were used in gas ventilation and then in partial liquid
ventilation (PLV). I:E ratios were changed either by modifying pause (1:2, 1:1, and 2:1; Group
1) or by modifying inspiratory flow rate (1:3, 1:1, and 2:1; Group 2). With increasing I:E ratio in
all subjects, PaCO2 decreased significantly (74 mmHg, 66 mmHg, and 66 mm Hg; p = .006),
PaO2 increased significantly (80 mmHg, 143 mmHg, and 147 mm Hg; p = .001). The change of
PaO2 by changing the I:E ratio was 49 % in PLV and 14 % in GV (p = .003). Lim et al
concluded that increasing the I:E ratio by adding pause enhanced gas exchange in partial liquid
ventilation. The researchers also concluded that the I:E ratio had a greater effect in the
oxygenation of partial liquid ventilation than in gas ventilation. This article is related to the
present study via the I:E ratios 1:2 and 2:1.
After reviewing the literature, tracheostomy tubes have important benefits in improving
weaning success. Aerosol therapy can be easily inhaled through a tracheostomy tube if the
proper interface is used. When inhaling antibiotic drugs via nebulizers, the drug levels in
pulmonary secretions exceed by several doses when compared to the levels expected with
intravenous administrations. Albuterol delivery through the tracheostomy tube was affected by
the patient's interface, delivery method, and bias gas flow. In delivering albuterol, the T-piece
was more efficient than the tracheostomy mask, the pMDI with valved holding chamber was
more efficient than the nebulizer and the pMDI was more efficient in delivering albuterol when a
T-piece was placed close to the spacer device than when placed in the distal position. Moreover,
I:E ratio and pressure wave combination helped optimize oxygenation, ventilation, and mean
airway pressure. The I:E ratio had a greater effect in the oxygenation of partial liquid ventilation
than in gas ventilation.
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CHAPTER III
METHODS
This is in vitro study. It consisted of three main interfaces, the tracheostomy collar, the
Wright mask and aerosol mask. In all interfaces, two I:E ratios of 1:2 and 2:1 were used. The
tracheostomy collar was tested with both opened and closed fenestration of the tracheostomy
tube. This chapter explained the methodology used to answer the following questions:
1. What is the amount of albuterol delivered to the lungs with different interfaces using an
open fenestration hole of the tracheostomy tube?
2. How much albuterol is delivered using a tracheostomy collar, while the fenestration hole
is opened and closed?
3. What is the effect of I:E ratio on aerosol delivery in simulated spontaneously breathing
adults with tracheostomy?
Experimental Setup
As shown in Figure 1 a teaching mannequin (Medical Plastic Labs, Gatesville, TX) with
a tracheostomy opening was used. Two of the mannequin's bronchi were connected to a "Y"
adaptor, which was attached to a collecting filter (Respirgard ™ II 303, Vital Signs, Englewood,
CO), which was connected to an inhalation port of a breathing simulator (Harvard Apparatus
Dual Phase Control Respirator Pump, Holliston, MA) through a corrugated tube.
The breathing parameters of this study included f 20/min, and Vt 400 mL (Piccuito &
Hess, 2005). The I:E ratios were adjusted in the first and second comparisons at 2:1 and 1:2,
respectively. The nebulizer was operated by a flow meter (Timemeter, St. Louis, MO) at 8 L/min
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with 100% oxygen. In every condition, the flow was discontinued at the end of nebulization. The
jet nebulizer was attached to the tracheostomy collar in the first group, the Wright mask in the
second group, and the aerosol mask in the third group.

Figure 1. The experimental setup of the study.
Interfaces
As shown in Figure 2, the interfaces used in this study included a tracheostomy collar
(AirLife™, Cardinal Health, McGaw Park, IL), a Wright mask (Wright Solutions LLC,
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Marathon, FL), and an aerosol mask (AirLife™, Cardinal Health, McGaw Park, IL). A adult
fenestrated tracheostomy tube (Shiley™, Mallinckrodt Medical Inc, Boulder, CO), size 8 mm,
was placed into the mannequin's stoma. The cuff was always deflated. Each interface was tested
in triplicate (n = 3), using I:E ratios of 1:2 and 2:1.

Figure 2. The different interfaces of the study: (A) Wright mask, (B) Tracheostomy collar, and
(C) Aerosol mask.
Data Collection
While the Wright mask and the aerosol mask were tested with an opened fenestration
hole, the tracheostomy collar was tested with the fenestration hole opened and closed. Each
interface was tested in triplicate (n=3). A jet nebulizer (eValueMed, Tri-anim, Sylmar, CA)
aerosolized 2.5 mg / 3 mL of albuterol sulfate (Dey Pharma Inc, Napa, CA) in each experiment.
After eluting the collecting filter with 0.1% HCl, the filter was shaken for 3 minutes to ensure
proper mixing. The absorption of the solution washed from the filter was measured with a

21

spectrophotometer (DC Series 500, Beckman Instruments, Fullerton, CA) at a wavelength of 276
nm using a 1-mL quartz cuvette. A total of 24 experiments were conducted and the same
protocol was followed for each experiment. The testing system was checked for correct interface,
I:E ratio, and condition of the fenestration hole before testing.
Data Analysis
The amount of aerosol deposited on the filter was quantified as a percentage of the
emitted dose. The descriptive statistics including the mean and standard deviations were
calculated for each condition tested in this study. Paired t-tests were conducted to evaluate
differences in the mean inhaled presence of dose delivered by the jet nebulizer between two I:E
ratios. One-Way Analysis of Variance (ANOVA) and Scheffe post-hoc multiple comparison
were utilized to determine differences among the means for tracheostomy collar, Wright mask,
and aerosol mask. Repeated measure ANOVA and Pairwise comparison were utilized to
determine differences among the means between two fenestration holes. All data analysis was
prepared using predictive analysis software (PASW, version 18.0), and statistical significance
was defined as p < .05.
The research methods were directed by the study questions; what is the amount of
albuterol delivered to the lungs with different interfaces using an open fenestration hole of the
tracheostomy tube? how much albuterol is delivered using a tracheostomy collar, while the
fenestration hole is opened and closed? and what is the effect of I:E ratio on aerosol delivery in
simulated spontaneously breathing adults with tracheostomy? Three different interfaces,
tracheostomy collar, Wright mask and aerosol mask were used. A Harvard Dual breathing
simulator was used. The PASW, version 18.0 helped to control data analysis.
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CHAPTER IV
RESULTS
This study compared tracheostomy collar, Wright mask, and aerosol mask with one
another to quantify the amount of aerosol delivery to a patient with tracheostomy receiving those
types of interfaces. Differences were considered statistically significant when p < .05. The
questions that were answered in this section include the following:
What is the amount of albuterol delivered to the lung with different interfaces using
an opened fenestration hole of the tracheostomy tube?
With an open fenestration hole the amounts of albuterol delivered to the lung with tracheostomy
collar, Wright mask, and aerosol mask with 1:2 ratio were 6.98 ± .80 %, 4.08 ± .56 %, and 3.46 ±
.04 %, respectively. The amounts of albuterol delivered to the lung with tracheostomy collar,
Wright mask, and aerosol mask with 2:1 ratio were 11.57 ± 1.38 %, 7.15 ± .55 %, and 6.11 ± .46
%, respectively. There was a significant statistical difference between groups (p = .001). As
shown in Figure 3 the highest deposition was with the tracheostomy collar, while the lowest
deposition was with the aerosol mask.
How much albuterol is delivered using a tracheostomy collar, while the fenestration
hole is opened or closed?
The results of opened fenestration were answered in the previous question. The amount of
albuterol delivered while fenestration closed with 1:2 ratio was 9.37 ± 1.45 % compared to 12.44
± 1.38 % with 2:1 ratio. There was a significant statistical difference between the fenestration
closed with 2:1 ratio vs. fenestration opened with 1:2 ratio (p = .04). As shown in Figure 3 the
deposition was higher with closed fenestration.
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What is the effect of I:E ratio on aerosol delivery in simulated spontaneously
breathing adults with tracheostomy?
In all groups, the total deposition was higher with 2:1 ratio 8.28 ± 2.63 % compared with 1:2
ratio 4.84 ± 1.69 %. In all opened fenestration experiments, there were significant statistical
differences between 1:2 ratio vs. 2:1 ratio (p < .05). However, with closed fenestration in the
tracheostomy collar group there was no significant statistical difference between 1:2 vs. 2:1
ratios (p = .18); see Figure 3. The longer the inspiratory time, the greater the amount of aerosol
deposition.

Figure 3. Inhaled mass percents among different interfaces at 1:2 and 2:1 ratios. (*) denotes p <
.05.
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In all cases, aerosol delivery was greater with the tracheostomy collar than the Wright
mask and aerosol mask (p < .05). Closing the fenestration hole with the tracheostomy collar
increased aerosol deposition significantly at 2:1 ratio compared to opening the fenestration hole
with 1:2 ratio (p = .04). I:E ratio and aerosol delivery were directly related. Increasing I:E ratio
from 1:2 to 2:1 improved aerosol delivery significantly in all opened fenestration experiments (p
< .05).
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CHAPTER V
DISCUSSION
The main purpose of this study was to investigate aerosol delivery with the Wright mask
and compare it to aerosol delivery with the tracheostomy collar and aerosol mask at different I:E
ratios. As answering the research questions: What is the amount of albuterol delivered to the
lungs with different interfaces using an open fenestration hole of the tracheostomy tube? How
much albuterol is delivered using a tracheostomy collar, while the fenestration hole is opened
and closed? What is the effect of I:E ratio on aerosol delivery in simulated spontaneously
breathing adults with tracheostomy? The study revealed that there is a significant amount of
aerosol deposition when using jet nebulizer with tracheostomy collar when compared to the
Wright mask and aerosol mask. The following discussion will look more closely at observations
noted during the study and how this study was compared with the literature. It will also look at
the clinical implications of the study, limitations of this study, and future studies needed.
OBSERVATIONS
Interfaces.
The results show greater delivery via tracheostomy collar than with the Wright mask and
aerosol mask. The amount of albuterol delivered was significantly lower with the aerosol mask
and the Wright mask. This was presumably the result of aerosol wasted into the air and in the
upper airways above the stoma. When using the Wright mask and aerosol mask, aerosol travels
through the nose, mouth and extrathoracic airways, which causes part of the aerosol delivered to
be deposited before it reaches the collecting filter, thus reducing the effectiveness of aerosol
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delivered with the Wright mask and the aerosol mask. It was not surprising that more aerosol
particles were delivered with the tracheostomy collar when compared to all other interfaces in
this study. It was observed that when the fenestration hole closed during the tracheostomy collar
experiments, aerosol particles were forced to deposit in the lower airways. It was also observed
that using a tracheostomy collar reduced the amount of drug wasted to the atmosphere.
Moreover, using a tracheostomy collar caused aerosol particles to travel shorter distances to
reach the collecting filter when compared to the Wright mask and the aerosol mask. In addition,
it was observed that during the expiratory phase there were more aerosol particles exiting from
the tracheostomy compared to the mouth and nose.
The Wright mask interface deposition results were lower than the tracheostomy collar
interface deposition results. The initial expectation was that there would be greater deposition,
especially when compared to the tracheostomy collar and aerosol mask interfaces. This was
because the Wright mask has both a tracheostomy collar and an aerosol mask integrated in its
design. Carvalho et al. (2010) evaluated the feasibility of the Wright mask and its efficacy with
humidity. They concluded that there were no big differences noted in blood oxygen saturation,
comfort, ease of use, or ease of breathing with the Wright mask compared to the tracheostomy
collar and aerosol mask.
The result of the tracheostomy collar and fenestration closed at 1:2 ratio 9.37 ± 1.45 % is
different than the result by Piccito and Hess (2005) when they compared tracheostomy collar vs.
T-piece useing a non fenestrated tracheostomy tube at 1:2 ratio 12.9 ± 1.3 %. The diffrence
between the results of the two studies stems from the fact that the experimental models were
different. In addition, in this study, the cuff was deflated at all times allowing some aerosol
particles to deposit in the upper airways. In addition, the Wright mask results indicated that there
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were no big differences in aerosol depositions compared to the aerosol mask. It was also
indicated that the Wright mask was less efficient compared to the tracheostomy collar.
Therefore, the results of this study matches the results presented by Carvalho et al (2010).
Carvalho and his colleagues indicated that the Wright mask did not have a big difference in the
efficiency and feasibility when compared to the tracheostomy collar and aerosol mask.
I:E ratios.
The I:E ratio of 2:1 lead to more aerosol deposition in this study than that for 1:2. The
difference in the amount of deposition between these I:E ratios can be explained by the breathing
pattern and the respiratory phase in which the medication was delivered. With I:E ratio of 2:1,
the inspiratory time is longer than it is with 1:2, which allows for more time to inhale the
aerosolized drug, thus, causing more aerosol deposition in the lungs. In all fenestrated opened
experiments, the amount of aerosolized albuterol deposition was affected significantly by the I:E
ratio. These results matched the results by Lim et al. (1999) which indicate that increasing the I:E
ratio by adding pause improved gas exchange in PLV. Oxygenation in PLV was affected by the
I:E ratio to a greater degree than in gas ventilation.
Fenestration Hole.
In this study, aerosol deposition obtained from the tracheostomy tube while the
fenestration closed was larger when compared to the open fenestration hole. The difference in
the amount of deposition between fenestration opened and fenestration closed can be explained
by the fact that aerosol was forced to go toward the collecting filter when the fenestration hole
was closed. However, when the fenestration hole was opened some of the aerosol was leaking
out of the hole and deposited up into the mouth and nose. This indicates that the pathway through
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which medication was delivered affected the amount of aerosolized albuterol deposited
significantly. This was confirmed by comparing the amount of aerosol deposition between
fenestration closed with 2:1 ratio vs. fenestration opened with 1:2 ratio. The amount of aerosol
deposited was greater with closed fenestration as compared to opened fenestration. This confirms
that whether opened or closed the fenestration hole has a major impact on the aerosol deposition
for the reasons mentioned earlier. This fact makes it logical that delivering aerosol therapy via
tracheostomy collar will have the most aerosol deposition, which was the case in this study.
During the expiration phase, it was noticed that aerosol was exiting from the stoma. Aerosol
therapy administration using a tracheostomy collar with an I:E ratio of 2:1 and closed
fenestration hole had the highest results, showing a greater delivery via tracheostomy collar than
with the Wright mask and aerosol mask.
The anatomic dead space of a tracheostomy tube ID 7.5 mm is between 5 and 6 mL
(Pierson, 2005). One study in cadavers determined the anatomic dead space of the extrathoracic
airways (not including the trachea and main bronchi) to be roughly 75 mL (Nunn, Campbell, &
Peckett, 1959). This is more than the dead space measured with tracheostomy tubes. Therefore, a
tracheostomy tube reduces anatomic dead space. Thus, the amount of aerosol therapy delivered
via tracheostomy collar is expected to be greater when compared with the Wright mask and the
aerosol mask due to the reduced dead space. A review by Epstein (2005) stated that
tracheostomy tubes can decrease dead space by 100 mL, when compared to a spontaneously
breathing patient. In addition, when the fenestration hole is closed, aerosol mists are forced to go
to the lungs; thus they will not be lost in the extrathoracic dead space including the nose and
mouth. The previous discussion proves that among the three interfaces investigated in this study,
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aerosol delivery with a tracheostomy collar with an I;E ratio of 2:1and closed fenestration had
the highest aerosol deposition in the filter.
Clinical Implications
Based on this study, three important recommendations can be given to clinicians to
achieve a better outcome when administering aerosolized Medications. First, use a tracheostomy
collar whenever is possible to administering aerosolized medications. Second, close the
fenestration hole during aerosol administration. Third, instruct the patient to inhale the
aerosolized medication slowly and instruct them to hold their breath for seconds after inspiration.
Limitations
Because this experiment was an in vitro bench study, the results should be subjected to
clinical validation. Different patients' breathing patterns may be seen in vivo. In addition, a
homogenous breathing simulator was used. Human test subjects would show heterogeneous
breathing patterns and different lung conditions. This investigation did not study the effect of
different breathing patterns. The parameters were the same in all experiments. This study was
conducted on only one type and size of tracheostomy tube.
Future Studies
The effect of changing the respiratory setting should be explored to determine how
aerosol delivery would be affected in different patients’ conditions, different diseases, and
different ventilatory managements. Different I:E ratios should be explored further to help
patients in relieving their symptoms and to provide guidance to clinicians on how to administer
aerosol therapy. In addition, different types and sizes of tracheostomy tubes should be studied in
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order to help other patients with different sizes or different types of tracheostomy tubes such as
pediatrics tracheostomy tubes.
Conclusion
This study indicates that the use of a tracheostomy collar is the best method of delivering aerosol
therapy when compared with the Wright mask and aerosol mask. The I:E ratio of 2:1 caused
greater aerosol deposition when compared to I:E ratio of 1:2. The aerosol deposition was better
when the fenestration hole was closed compared with opened fenestration using the
tracheostomy collar.
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